Kixta 125mg Capsule Supplier USA | Pharmaceutical Exporter from India

Kixta 125mg Capsule: Advanced CDK4/6 Inhibition for Targeted Breast Cancer Therapy

Are you searching for a reliable Kixta 125 mg capsule exporter from India? Ernest Oncology, a specialized division of Ernest Pharmaceutical Pvt. Ltd., is a premier global supplier and bulk distributor of advanced oral targeted therapies. We maintain a high-authority, regulatory-compliant supply chain serving the USA, UK, Australia, and South Africa, ensuring that life-saving oncology medications reach healthcare providers with pharmaceutical-grade integrity and efficient global logistics.

Detailed Product Overview: What is Kixta 125 mg?

Kixta 125 mg is a high-potency oral capsule containing the active pharmaceutical ingredient Palbociclib. It belongs to a breakthrough class of medications known as Cyclin-Dependent Kinase (CDK) 4 and 6 inhibitors.

Manufactured by Zydus Healthcare Limited, Kixta 125mg is a precision-engineered therapy designed to combat specific types of advanced cancers by interfering with the molecular machinery of cell division. For international B2B procurement, Kixta offers a world-class, cost-effective alternative to innovator brands, providing critical support for patients with advanced-stage malignancies.

Primary Therapeutic Indications

Kixta 125mg Capsule is clinically indicated for the management of:

1. HR+/HER2- Metastatic Breast Cancer: Treatment of hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced or metastatic breast cancer.

2. Combination Therapy: It is typically prescribed in combination with endocrine-based therapies:

• With an aromatase inhibitor (such as letrozole) as initial endocrine-based therapy in postmenopausal women.

• With fulvestrant in women whose disease has progressed following endocrine therapy.

Mechanism of Action: How Kixta 125mg Works

Kixta (Palbociclib) utilizes a targeted approach to stop the progression of the cell cycle:

• CDK4/6 Inhibition: It selectively blocks cyclin-dependent kinases 4 and 6 (CDK4/6). These proteins act as "checkpoints" that push cells from the growth phase (G1) into the DNA synthesis phase (S).

• Cell Cycle Arrest: By inhibiting these kinases, Kixta prevents cancer cells from dividing and multiplying. This "arrests" the cancer cell cycle, effectively slowing tumor growth and reducing the volume of the primary tumor and metastases.

• Synergistic Effect: When combined with anti-estrogen therapies, it further reduces the phosphorylation of the retinoblastoma (Rb) protein, leading to a more profound inhibition of cancer cell proliferation compared to hormonal therapy alone.

Administration and Safety Guidelines

• Administration: The standard dose is one 125 mg capsule taken orally once daily for 21 consecutive days, followed by 7 days off treatment (a 28-day cycle).

• With Food: Kixta should be taken with food to maintain consistent drug levels in the blood and improve absorption. Swallow the capsule whole; do not chew, crush, or open it.

• Key Precautions:

• Neutropenia: This medication can significantly lower white blood cell counts. Regular Complete Blood Counts (CBC) are mandatory before and during treatment.

• Infection Risk: Patients should immediately report signs of fever or chills to their oncologist.

• Lung Inflammation: Patients should be monitored for new or worsening respiratory symptoms (e.g., dry cough or shortness of breath).

• Avoid Grapefruit: Grapefruit and grapefruit juice can increase the levels of the medicine in your body and should be avoided.

Why Source Kixta 125 mg from Ernest Oncology?

• Strategic Indian Exporter: Direct access to Zydus’ manufacturing excellence, ensuring 100% authenticity and competitive bulk pricing for international B2B markets.

• Global Distribution Mastery: Expertise in navigating the regulatory and customs landscapes of the USA, UK, Australia, and South Africa.

• Bulk Supply Reliability: We specialize in large-scale exports for oncology hospitals, specialty clinics, and regional distributors, ensuring treatment continuity.

• Secure Logistics: Professional-grade packaging and tracked shipping to maintain the chemical stability and safety of the medication during transit.